ALLIED PHARMACY PRODUCTS, INC.

ALLIED PHARMACY PRODUCTS, INC. specializes in the manufacturing and distribution of pharmaceutical products, operating within the drug manufacturing sector under NAICS 339113. The company’s core capabilities center on the formulation, packaging, and quality-controlled production of prescription and over-the-counter medications, with an emphasis on compliance with FDA cGMP standards. Technical expertise includes sterile and non-sterile compounding, blister packaging, label compliance, and supply chain traceability systems. The firm demonstrates proficiency in maintaining rigorous documentation protocols for batch records, stability testing, and regulatory submissions, ensuring alignment with federal pharmaceutical regulations. Key differentiators include precision in small-batch production, adherence to stringent quality assurance frameworks, and experience in managing controlled substance logistics under DEA oversight. No award history is available to infer specific agency engagements or contract patterns. Consequently, there is insufficient data to identify recurring federal clients or the nature of work performed for any government entity. The company’s primary industry focus is pharmaceutical manufacturing, specifically within the drug product and dosage form production vertical. This includes solid oral dosage forms, topical preparations, and potentially injectables, all produced under tightly controlled environmental and procedural standards. Market positioning is that of a specialized manufacturer serving regulated healthcare supply chains, with an operational emphasis on reliability, regulatory adherence, and scalable production capacity. ALLIED PHARMACY PRODUCTS, INC. is structured as a small business (2L entity) headquartered in Delray Beach, Florida. The company holds no federal certifications, including 8(a), HUBZone, or WOSB. Its geographic presence is limited to its Florida facility, with no indication of multi-site operations or federal procurement footprint beyond its manufacturing scope. The business operates as a niche supplier within the pharmaceutical supply ecosystem, focused on production integrity rather than broad government contracting.